Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Daudon
Paul Jungers

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Nephron. Physiology|October 23, 2004
Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculiMichel Daudon, Paul Jungers
Current Diabetes Reports|February 8, 2008
Diabetes and nephrolithiasisMichel Daudon, Paul Jungers
Drugs|February 12, 2004
Drug-induced renal calculi: epidemiology, prevention and managementMichel Daudon, Paul Jungers
Urological Research|February 14, 2006
Influence of body size on urinary stone composition in men and womenMichel Daudon, Bernard Lacour, Paul Jungers
Drugs|December 22, 2017
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and TreatmentMichel Daudon, Vincent Frochot, Dominique Bazin, et al.
The Journal of Urology|February 23, 2010
Stone formation and pregnancy: pathophysiological insights gained from morphoconstitutional stone analysisPaul Meria, Haider Hadjadj, Paul Jungers, et al.
Urological Research|May 6, 2004
Changes in stone composition according to age and gender of patients: a multivariate epidemiological approachMichel Daudon, Jean-Christophe Doré, Paul Jungers, et al.
Urolithiasis|February 3, 2018
Recurrence rates of urinary calculi according to stone composition and morphologyMichel Daudon, Paul Jungers, Dominique Bazin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Urinary stones and urinary tract abnormalities. Is the stone composition independent of the anatomical abnormality?]Michel Daudon, Fabrice Cohen-Solal, Bernard Lacour, et al.
Journal of the American Society of Nephrology : JASN|June 16, 2006
Type 2 diabetes increases the risk for uric acid stonesMichel Daudon, Olivier Traxer, Pierre Conort, et al.
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Nephron. Physiology|October 23, 2004
Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculiMichel Daudon, Paul Jungers
Current Diabetes Reports|February 8, 2008
Diabetes and nephrolithiasisMichel Daudon, Paul Jungers
Drugs|February 12, 2004
Drug-induced renal calculi: epidemiology, prevention and managementMichel Daudon, Paul Jungers
Urological Research|February 14, 2006
Influence of body size on urinary stone composition in men and womenMichel Daudon, Bernard Lacour, Paul Jungers
Drugs|December 22, 2017
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and TreatmentMichel Daudon, Vincent Frochot, Dominique Bazin, et al.
The Journal of Urology|February 23, 2010
Stone formation and pregnancy: pathophysiological insights gained from morphoconstitutional stone analysisPaul Meria, Haider Hadjadj, Paul Jungers, et al.
Urological Research|May 6, 2004
Changes in stone composition according to age and gender of patients: a multivariate epidemiological approachMichel Daudon, Jean-Christophe Doré, Paul Jungers, et al.
Urolithiasis|February 3, 2018
Recurrence rates of urinary calculi according to stone composition and morphologyMichel Daudon, Paul Jungers, Dominique Bazin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Urinary stones and urinary tract abnormalities. Is the stone composition independent of the anatomical abnormality?]Michel Daudon, Fabrice Cohen-Solal, Bernard Lacour, et al.
Journal of the American Society of Nephrology : JASN|June 16, 2006
Type 2 diabetes increases the risk for uric acid stonesMichel Daudon, Olivier Traxer, Pierre Conort, et al.
Pageof 20